We believe the future should be seen, not just imagined

Neal, the co-founder and CEO of our company, holds a PhD in Biology from Columbia University. His research expertise lies in modeling human diseases in small animals using molecular imaging, animal genetics, and surgical techniques. With prior faculty positions at Columbia University and the University of Washington, Neal brings a wealth of research experience to his role. As the driving force behind our business and hardware development, he spearheads our company’s vision and strategic direction for preclinical R&D services.

Alexander, the co-founder and CTO, obtained his PhD from the Freie University in physics specializing in particle and radiation transport, inverse scattering problems, and computational modeling. Over the past two decades, he has dedicated his expertise to solving intricate medical challenges, particularly in the realm of preclinical molecular imaging. Alexander is at the forefront of pioneering novel image reconstruction algorithms, driving advancements in automated data analysis, and leveraging the power of cloud computing to build a modern image analysis software.

Darren is a seasoned senior software developer with a foundation in mathematics from the University of Maryland. Leveraging his background in data science, Darren possesses a diverse coding skill set with expertise in multiple programming languages, particularly Python, as well as proficiency in Machine Learning and AI. With a comprehensive professional journey spanning various domains, including 4 years as a signal processing engineer for a Fortune 500 company, and over 8 years of experience freelancing and contributing to startups, Darren brings a wealth of software expertise to InvivoAX.

Ken, the Director of Mechanical Engineering, obtained his BS in Mechanical Engineering from MIT in 1978. Throughout his career, he has honed his expertise in product development, including many years at leading manufacturers developing small animal imaging products. Ken’s extensive experience in managing the entire design-to-manufacturing process has been instrumental in cultivating a small yet highly efficient engineering and manufacturing team. Leveraging the latest advancements in rapid prototyping, coupled with his comprehensive knowledge of national and international manufacturers, Ken excels in delivering streamlined and efficient product development, ensuring that our imaging tools work flawlessly.

Chase is an accomplished full-stack software developer who specializes in machine learning. With his versatile skills and language-agnostic approach, he brings a unique expertise in modern SaaS, particularly in the fin-tech and cryptocurrency sectors. This invaluable knowledge seamlessly translates into the preclinical R&D SaaS environment, where the need for robust data security and intuitive data visualization is of paramount importance, ensuring a harmonious integration of these critical aspects.

Chris is Professor and Chair of Biomedical Engineering (BME) and Microbiology & Molecular Genetics; and Director, Institute for Quantitative Health Science & Engineering (IQ) at Michigan State University. Chris is a founding member and served as president of the World Molecular Imaging Society. In 1995 Chris co-founded Xenogen, to commercialize optical in vivo imaging systems with advanced fluorescent and bioluminescent detection capability to accelerate preclinical drug discovery and development. Chris oversaw the early product development of the IVIS system from when he submitted the first patents in 1995 to when the company was acquired in 2006. Chris served as Chair of the Scientific Advisory Board at Xenogen until it was acquired by Caliper Life Sciences. Chris brings InVivo Analytics decades of experience in the preclinical optical imaging field and his unique understanding and vision of optical imaging will guide InVivo Analytics to develop a relevant commercially viable products.

Steve brings InVivo Analytics an experienced entrepreneur with a career of building successful companies by combining technology, innovation, and operational excellence to create value. As CEO of Comark, Steve grew the company by providing automation solutions for mission critical life safety, vision, medical and military applications. Prior to Comark, as part of the startup team at Avidyne, Steve led the pioneering development of an certified affordable glass cockpit and synthetic vision. Steve has held senior positions at Cognex (CGNX), and Bytex (BYTX) from early stage through IPO and sale. Steve holds a Bachelor’s of Science in Electrical Engineering from the University of Massachusetts, Lowell.

Kevin is a Fellow at PerkinElmer’s Innovation Group with a role as a “thought-leader” responsible for helping to direct the company’s current and next generation imaging technology to market. Kevin also splits his time as a Visiting Professor at UCLA and Texas A&M. Kevin has been involved with the IVIS optical system development and biological applications since 1999 when he joined Xenogen. Kevin brings decades of experience in the preclinical imaging market with a broad knowledge base of both the applications side and a unique understanding of the preclinical imaging market.

David Panzarella, MBA, advises on business development, sales pipeline, and market expansion. Mr. Panzarella has over 15 years of experience within research imaging, leading the global commercial infrastructure which included sales, service, field applications and customer support for PerkinElmer, Caliper Life Sciences and Xenogen. He has become a cornerstone within preclinical imaging in developing strategic customer partnerships while setting the bar for technology support within the imaging community. Prior to joining Xenogen, he held commercial positions with Biospace, Cerner, WebMD and Critikon (a J&J company). David is currently VP of Commercialization at Standard Biotools.